2020 annual financial data
Axsome Therapeutics 2020 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -99,141,328 USD and net income was -102,900,600 USD.
Operating cash flow was -78,456,569 USD.
Get free Axsome Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -99,141,328 USD
- Net income
- -102,900,600 USD
- Operating cash flow
- -78,456,569 USD